Please assess the completion status of the following clinical trial:

Trial Title: A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Men and women \>=18 years of age~* Diagnosis of Crohn's~* Crohn's disease of at least 3 months duration, with colitis, ileitis, or ileocolitis, confirmed by radiography or endoscopy~Exclusion Criteria:~* Local manifestations of Crohn's disease such as strictures, abscesses, or other disease~* Surgery for bowel diversion with placement of a stoma within 3 months prior to beginning the study~* Positive stool culture

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).